# Case Report: Lymphangiogram and embolization for malignant chylothorax in cancer patients

**Authors:** John T. Moon, Hanzhou Li, Omar Abdalla, Nicholas Swilley

PMC · DOI: 10.3389/fonc.2025.1586047 · 2025-05-12

## TL;DR

This case report shows that lymphangiogram and embolization can effectively treat malignant chylothorax in cancer patients when conventional methods fail.

## Contribution

The paper highlights the underreported use of lymphangiogram and embolization for non-iatrogenic malignant chylothorax in cancer patients.

## Key findings

- Thoracic duct embolization significantly reduced chyle drainage in patients with high-output malignant chylothorax.
- The procedure allowed continuation of cancer therapy and improved patient outcomes.
- Lymphangiogram and embolization proved effective even in patients with prior surgical interventions.

## Abstract

Tumor-related lymphatic obstruction can cause malignant chylothorax, which can be debilitating. Conventional management includes dietary modifications, percutaneous drainage, and medical management (octreotide), most of which prove refractory in high-output chylothorax cases. Lymphangiogram and embolization in such cases offers a minimally-invasive alternative; however, its use in non-iatrogenic malignant chylothorax is underreported. We present three cases of malignant chylothorax managed with lymphangiogram followed by therapeutic embolization. Case 1: A 70-year-old female with relapsed angioimmunoblastic T-cell lymphoma presents with bilateral chylous effusions refractory to conventional management. Following thoracic duct embolization (TDE) drainage output decreased from over 600 mL/day to less than 200 mL/day, permitting resumption of systemic therapy and subsequent autologous stem cell transplantation. Case 2: A 28-year-old female with ALK-positive non–small cell lung cancer presents with severe respiratory compromise due to extensive mediastinal disease and high-output chylothorax (>1 L/day) refractory to conventional therapy. TDE reduced drainage to less than 150 mL/day, allowing for continued targeted therapy. Case 3: A 70-year-old female with HER2-positive, ER-/PR– breast cancer presents with recurrent right-sided chylothorax despite prior surgical lymphatic ligations. Direct lymphatic leak embolization resulted in marked reduction of chylous output and significant symptom relief. Lymphangiogram with embolization is a safe and effective intervention for malignant chylothorax, regardless of surgical history. Early intervention can alleviate chyle leaks, facilitate ongoing cancer therapy, and improve patient outcomes, making it an important option in multidisciplinary oncology care.

## Linked entities

- **Diseases:** angioimmunoblastic T-cell lymphoma (MONDO:0004977), non–small cell lung cancer (MONDO:0005233), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}
- **Diseases:** angioimmunoblastic T-cell lymphoma (MESH:D016399), chylothorax (MESH:D002916), chylous effusions (MESH:D002915), lymphatic leak (MESH:D008206), non-small cell lung cancer (MESH:D002289), respiratory compromise (MESH:D012131), breast cancer (MESH:D001943), mediastinal disease (MESH:D008477), chyle leaks (MESH:D019559), Tumor (MESH:D009369)
- **Chemicals:** octreotide (MESH:D015282)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12104046/full.md

---
Source: https://tomesphere.com/paper/PMC12104046